Peripheral neuropathy as potential side effect in patients with multiple sclerosis treated with teriflunomide.
What it found
We found no results in the registry or in papers.
What was tested
Treatment tested
- Teriflunomide
Dihydroorotate dehydrogenase inhibitor
What it measured
Main measures
For both upper limbs, the investigators will record:
Arm and hand function
Other measures (1)
For both upper limbs, the investigators will record:
Arm and hand function
Who could take part
MS (type not specified)
Inclusion: Patients with previous diagnosis of multiple and currently treated with teriflunomide. Exclusion: Patients with known peripheral nerve abnormalities of other origin than teriflunomide toxicity.
As registered. Criteria can change, so ask the trial team or your neurologist.
About this trial
In the sponsor's words
To explore the incidence of peripheral nerve abnormalities, investigated by Nerve Conduction Study, in patients with multiple sclerosis treated with teriflunomide.
Loading reviews and guidelines…
Related trials
- TDM-MS
Phase 4 · Status unknown
No result found
- TERIFIN
Phase 4 · Completed
No result found
- STATURE
Status unknown
No result found
- Teriflunomide Tecfidera LMCE
Completed
Result in a paper, not read yet
- A Study to Evaluate the Pharmacokinetic Profiles of Singl…
Phase 1 · Completed
No result found
- An Observational Study on Teriflunomide-exposed Pregnancies
Completed
No result found
History
Started
Jun 2021
Assembled by software from public sources and not checked by people. Each record links to its source. Report an error